time

topic

speaker

08.50

Opening and Intro

Dr. Anton Pozniak

Chelsea & Westminster Hospital

09.00

"Clinical Utility of HLA-B*5701 Testing"
Session supported by
GlaxoSmithKline Pharmaceuticals

Dr.Chloe Orkin
Barts and the London NHS Trust

10.00

10.20

"Managing complex naive patients”

Session supported by Gilead Sciences

TBC
North Manchester General Hospital

11.20

“Planning for Success”

Session supported by Janssen-Cilag Ltd

Dr. Laura Waters

St Mary’s Hospital

12.20

13.20

'A review of switching strategies for patients experiencing long term tolerability issues with their first line regimen'

ession supported by Boehringer Ingelheim

Dr Clifford Leen

14.20

Focus: Pharmacokinetics
Session supported by
BMS Pharmaceuticals

Dr Marta Boffito,
Chelsea & Westminster Hospital

15.20

15.40

Pharmocogenomics

Session supported by Delphic Diagnostics

TBC

16.40